Op-Eds
How to ensure sustainability and wider stakeholder acceptability in NLEM revisions
07-12-2022
Nilaya Varma, CEO and Managing Director, Primus Partners shares his thoughts on the 4th revision of the National List of Essential Medicines, in particular releasing frequent revisions to the list as well as providing greater financial incentives to pharma companies.
Explore Related Insights
- Changing public health needs and the role of capacity building Institutions in India
- From Fear To Hope: Reflecting On Over Three Decades Of The Fight Against HIV/AIDS
- Vaccine Rollout: A Shot In The Arm
- Corporate Social Responsibility In Mental Health: The Missing Link in India's Nation Building Strategy
